SCHEMBL5735463

SCHEMBL5735463

CC(C)C[C@H](Oc1ccc2ccncc2c1)C(=O)[O-].[Na+]

nearest known ligand 0.42

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG known ✓ P37231 4/20 0.41
MRGPRX4 Q96LA9 1/20 0.42
PPARA Q07869 4/20 0.41
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CTRC Q99895 1/20 0.38
PORCN Q9H237 1/20 0.38
CYP3A4 P08684 1/20 0.38
CACNA2D1 P54289 2/20 0.37
IKBKB O14920 1/20 0.37
NTSR1 P30989 1/20 0.37
ROCK2 O75116 2/20 0.36
HASPIN Q8TF76 1/20 0.36
LNPEP Q9UIQ6 1/20 0.36
NOTUM Q6P988 1/20 0.36
HIPK2 Q9H2X6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6482624 0.90 PPARG (0.49) MRGPRX4PPARGPPARACTRCPORCN
SCHEMBL6482619 0.90 PPARG (0.49) MRGPRX4PPARGPPARACTRCPORCN
SCHEMBL2073061 0.85 PPARG (0.56) MRGPRX4PPARGPPARALMNAMAPT
SCHEMBL8358819 0.85 KDM4E (0.48) MRGPRX4PPARGPPARAPORCNCYP3A4
SCHEMBL8363966 0.77 PPARG (0.71) MRGPRX4PPARGPPARAPORCNCYP3A4
SCHEMBL2073068 0.76 PPARG (0.69) MRGPRX4PPARGPPARACTRCPORCN
SCHEMBL2073059 0.76 PPARG (0.69) MRGPRX4PPARGPPARAPORCNCYP3A4
SCHEMBL30497290 0.75 IKBKB (0.48) MRGPRX4LMNAMAPTPORCNCYP3A4
SCHEMBL30575142 0.73 PPARG (0.53) PPARGPPARACTRC
SCHEMBL2074029 0.72 PPARG (0.53) MRGPRX4PPARGPPARAPORCNCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490056-B1 N-'4-(2-IMINO-PYRROLIDIN-1-YL)PHENYL)-ACETAMIDE AND CORRESPONDING PIPERIDINE DERIVATIVES AS FACTOR XA INHIBITORS FOR THE TREATMENT OF THROMBO-EMBOLIC DISEASES MERCK PATENT GMBH (DE) 2006-08-30 EP disclosed